Welcome to our dedicated page for Albemarle SEC filings (Ticker: ALB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating lithium volume forecasts or bromine pricing clauses in Albemarle鈥檚 250-page reports can feel overwhelming. Stock Titan solves this by turning Albemarle鈥檚 complex SEC filings into clear, actionable insight鈥攕o you can focus on decisions, not document hunts.
Every filing is here in real time, from the Albemarle annual report 10-K simplified to the latest Albemarle quarterly earnings report 10-Q filing. Our AI surfaces segment-level EBITDA, capex plans for Chilean brine assets, and risk factors tied to lithium prices鈥攚ithout scrolling through footnotes. Need to monitor management moves? Receive instant alerts on Albemarle insider trading Form 4 transactions and track Albemarle Form 4 insider transactions real-time to spot buying or selling patterns ahead of material events.
Common questions are answered in-line: 鈥淗ow do I understand Albemarle SEC documents with AI?鈥� Simply open any 8-K; our summary explains the supply-contract or environmental update in plain English. Curious about leadership pay? The Albemarle proxy statement executive compensation section highlights equity awards and performance metrics. Need context on sudden news? The platform links each Albemarle 8-K material events explained summary to prior disclosures, giving you timeline clarity in seconds.
Whether you鈥檙e reviewing catalysts margins, tracking debt covenants, or comparing Albemarle earnings report filing analysis across quarters, Stock Titan provides:
- AI-powered summaries that explain every form in simple terms
- AG真人官方-time EDGAR updates across 10-K, 10-Q, 8-K, S-8, and more
- Instant access to Albemarle executive stock transactions Form 4
- Downloadable data tables for quick model inputs
Spend less time parsing disclosures and more time understanding how Albemarle converts critical resources into shareholder value.
Krupa Ander C., identified as an officer (General Counsel & Secretary), reported an insider acquisition in Albemarle Corp (ALB) on 08/06/2025. The Form 4 shows an award of 7,430 restricted stock units (RSUs) granted at a $0 price and reported under transaction code A (acquisition).
The RSUs are described to vest 100% on August 6, 2028 per the award agreement. Following the reported grant the filing shows 11,771 shares beneficially owned by the reporting person. The form is signed by an attorney-in-fact on 08/08/2025.
Krupa Ander C., General Counsel & Secretary of Albemarle Corporation, reported beneficial ownership of 4,341 common shares, consisting of 1,560 issued shares and 2,781 restricted stock units granted across 2023鈥�2025 with staggered vesting through 2028. She also disclosed 2,676 stock options: 1,608 exercisable 02/27/2028 (exp. 02/26/2035) at $78.97 and 1,068 exercisable 02/22/2027 (exp. 02/21/2034) at $118.18. All holdings and vesting terms are reported on Form 3.
Franklin Resources, Inc. and several affiliated investment managers filed Amendment No. 1 to Schedule 13G reporting passive ownership of Albemarle Corporation (ALB) common stock as of 30 June 2025.
The group reports 9,722,191 shares beneficially owned, equal to 8.0 % of ALB鈥檚 outstanding shares. Franklin Advisers, Inc. accounts for 8,422,920 shares, including 3,887,547 shares issuable upon debt conversion. Sole voting power covers 9,332,953 shares and sole dispositive power 9,659,698 shares; 62,493 shares are subject to shared voting/disposition, primarily by Templeton Asset Management Ltd.
The filing, made under Rule 13d-1(b), states the holdings are in the ordinary course of business and not intended to influence control. Major individual shareholders Charles B. Johnson and Rupert H. Johnson, Jr. report zero direct ownership. Franklin Income Fund, an advised client, holds 6,475,850 shares (5.3 % of the class). No change-of-control plans, material transactions, or additional events are disclosed.
Albemarle Corporation (ALB) 鈥� Form 4 Insider Transaction
Director James J. O鈥橞rien reported two share acquisitions dated 1 July 2025:
- 2,725 common shares granted as the annual installment of non-employee director compensation under the company鈥檚 2023 Stock Compensation and Deferral Election Plan. These shares are scheduled to vest on 1 July 2026.
- 37 common shares issued in lieu of cash dividends that accrued on a prior award granted 1 July 2024 and fully vested on 1 July 2025.
Both transactions were reported with a $0.00 acquisition price, indicating they are equity compensation rather than open-market purchases. Following the two grants, O鈥橞rien鈥檚 direct beneficial ownership increased to 8,085 common shares.
No derivative securities were reported and no dispositions occurred. An Exhibit 24 Power of Attorney was filed to authorize the attorney-in-fact signature.
The filing is routine, reflecting scheduled director equity awards rather than discretionary insider buying or selling.
FAQ
What is the current stock price of Albemarle (ALB)?
What is the market cap of Albemarle (ALB)?
